openPR Logo
Press release

Technology Spending on Revenue Cycle Management Market Growth with Worldwide Industry Analysis to 2024

03-17-2017 01:53 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Technology Spending on Revenue Cycle Management Market Growth

Global Technology Spending on Revenue Cycle Management: Snapshot

The global technology spending on revenue cycle management is primarily being driven by the wide array of advantages that their implementation can offer, such as increase in revenue generation, better efficiency in healthcare practices, easier compliance with industry norms and regulations, and greater accuracy and easier access to healthcare IT systems. However, its market is currently being restricted by a host of issues, including the inability to handle uninsured patients, the losses and increased pressure incurred due to changes in regulations, the low mobility of a system in response to shifting market dynamics, and the overall concerns regarding the integrity and security of data.

Obtain Report Details @ http://www.transparencymarketresearch.com/technology-spending-revenue-cycle-management.html

The current trends in the global market for technology spending on revenue cycle management include a growing use of credit card programs that can aid and cover a greater percentage of a national population and allow healthcare organizations to access their medical data faster. The global market for technology spending on revenue cycle management is expected to reach an evaluation of US$51.56 bn by the end of 2024. It was calculated at US$28.50 bn at the end of 2015 and is expected to expand at a healthy CAGR of 6.9% within a forecast period from 2016 to 2024.

Companies Going for Cloud-based Revenue Cycle Management

Revenue cycle management can be dissected into integrated and stand-alone, on the basis of platforms. An integrated platform for revenue cycle management is a combined system for a healthcare organization’s financial performance management, a patient’s electronic health records (EHR), and business intelligence tools, all collected under a single revenue cycle solution. A stand-alone platform in revenue cycle management, on the other hand, can work independently of other solutions or software. It works individually without requiring patient health records or medical records integration. Based on deployment, revenue cycle management is segmented into cloud-based and on-premise. Cloud-based deployment is trending and has greater growth opportunities in the forecast years due to its accessibility and lower costs.

APAC Grows Stronger in Demand for Revenue Cycle Management

North America played the leading role among all key regions in technology spending on revenue cycle management in 2015. However, over the coming years, technology spending on revenue cycle management in Asia Pacific will exhibit the leading CAGR of 8.5%, between 2016 and 2024. Asia Pacific is therefore expected to hold an important position in the sustainable growth of the global technology spending on revenue cycle management industry over the above forecast period.

The Asia Pacific region is still relatively behind in terms of adoption and development of new technologies. Although the expenditures on technology in modern revenue cycle management is currently low in the region, the market is expected to grow substantially, owing to factors such as the positive modulations in global regulatory reforms, the evolving economic scenario and its consequent increase in purchasing power of consumers and enterprises, growing awareness of the advantages of modern revenue cycle management processes and the presence of a large and growing number of patients suffering from various chronic disorders. Japan currently represents a highly lucrative market in terms of spending, compared to the rest of the APAC nations.

Fill the form to gain deeper insights on this market @: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597

Cerner Corporation, McKesson Corporation, DST Systems, Inc., Allscripts, 3M, and Perot Systems have been some of the key players that have led the global market in technology spending on revenue cycle management. A large number of the more prominent entities from this market are known to be located within the U.S

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Technology Spending on Revenue Cycle Management Market Growth with Worldwide Industry Analysis to 2024 here

News-ID: 472613 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Cycle

Full Life Cycle API Management Market to Set New Growth Cycle | Mulesoft, Google …
Global Full Life Cycle API Management Market Report 2020, Covid 19 Outbreak Impact research report added by Report Ocean, predicts the industry’s performance for the upcoming years to help stakeholders in making the right decisions that can potentially garner strong returns. Further, the document provides comprehensive analysis of the key industry trends as well as the opportunities that will ensure an upward growth trajectory in the coming years. It also
Submarine AIP System Market Segmented By product type Closed Cycle Diesel Engin …
This Fact.MR Report examines, global submarine AIP system market for the forecast period 2017–2026. The prime purpose of the report is to find opportunities and trends in the market and provide insights pertaining to segments of the global submarine AIP system market. To understand the opportunities and trends in this market, the report is categorically divided into three sections namely on the basis of product type, fit type, and region. The
In-vitro fertilization (IVF) Market By Types of cycle (Fresh Cycle (Non-Donor), …
Global In-vitro fertilization (IVF) Market was valued at USD 507.98 Million in the year 2017. Global In-vitro fertilization (IVF) Market is further estimated to grow at a CAGR of 10.41 % from 2018 to reach USD 920 Million by the year 2023. North America region holds the highest market share in 2017 and Europe is considered as the fastest growing market in the forecasted period. At country level, developed markets
Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in …
McKesson Corporation, Allscripts, Cerner Corporation, and Optum Health, Inc. were the leading players in the global market for technology spending on revenue cycle management in 2015. These key companies show the common strengths in having built strong distribution channels and effective long-term partnerships. Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597 According to a research report released by Transparency Market Research, technology spending on revenue cycle management is expected to experience a buildup in competitive rivalries
Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in …
Global Technology Spending on Revenue Cycle Management: Snapshot The global technology spending on revenue cycle management is primarily being driven by the wide array of advantages that their implementation can offer, such as increase in revenue generation, better efficiency in healthcare practices, easier compliance with industry norms and regulations, and greater accuracy and easier access to healthcare IT systems. However, its market is currently being restricted by a host of issues,
Aeroderivative Gas Turbine Market By Technology (Open Cycle, Combined Cycle), In …
Combined cycle aeroderivative gas turbine market for 2015 was over 5 GW and looks set to see handsome growth. Rising acceptance across cogeneration electricity generating stations owing to its fast start and cycling capabilities will complement the business outlook. Aeroderivative Gas Turbine Market size will exceed 21 GW by 2024, as reported in the latest study by Global Market Insights, Inc. Rising cogeneration technology adoption to meet the growing electricity